Dicerna Pharmaceuticals, Inc. financial reports, Dicerna Pharmaceuticals, Inc. annual revenue in 2024. When does Dicerna Pharmaceuticals, Inc. report revenue?
Dicerna Pharmaceuticals, Inc. total revenue, net income and dynamics of changes in US dollar today
Net income Dicerna Pharmaceuticals, Inc. - -29 965 000 $. Information about net income is used from open sources. The dynamics of net income of Dicerna Pharmaceuticals, Inc. has changed by 6 621 000 $ in recent years. These are the main financial indicators of Dicerna Pharmaceuticals, Inc.. The financial graph of Dicerna Pharmaceuticals, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. Dicerna Pharmaceuticals, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Dicerna Pharmaceuticals, Inc. total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
47 603 000 $
+1 432.120 % ↑
-29 965 000 $
-
31/12/2020
40 956 000 $
+2 557.750 % ↑
-36 586 000 $
-
30/09/2020
48 875 000 $
+508.28 % ↑
-21 849 000 $
-
30/06/2020
40 448 000 $
+611.86 % ↑
-31 820 000 $
-
30/09/2019
8 035 000 $
-
-30 790 000 $
-
30/06/2019
5 682 000 $
-
-23 845 000 $
-
31/03/2019
3 107 000 $
-
-26 154 000 $
-
31/12/2018
1 541 000 $
-
-18 611 000 $
-
30/09/2018
1 545 000 $
-
-19 020 000 $
-
30/06/2018
1 545 000 $
-
-35 644 000 $
-
31/03/2018
1 545 000 $
-
-15 579 000 $
-
31/12/2017
1 418 000 $
-
-15 589 000 $
-
30/09/2017
474 000 $
-
-15 033 000 $
-
30/06/2017
252 000 $
-
-15 225 000 $
-
Show:
to
Dicerna Pharmaceuticals, Inc. financial report charts
The latest dates of Dicerna Pharmaceuticals, Inc. financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of Dicerna Pharmaceuticals, Inc. is available online for such a date - 31/03/2021. Gross profit Dicerna Pharmaceuticals, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Dicerna Pharmaceuticals, Inc. is 47 603 000 $
Dicerna Pharmaceuticals, Inc. quarterly report dates
Total revenue Dicerna Pharmaceuticals, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Dicerna Pharmaceuticals, Inc. is 47 603 000 $ Operating income Dicerna Pharmaceuticals, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Dicerna Pharmaceuticals, Inc. is -29 107 000 $ Net income Dicerna Pharmaceuticals, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Dicerna Pharmaceuticals, Inc. is -29 965 000 $
Current assets Dicerna Pharmaceuticals, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Dicerna Pharmaceuticals, Inc. is 594 500 000 $ Total assets Dicerna Pharmaceuticals, Inc. refers to the total amount of assets owned by a person or entity. Total assets Dicerna Pharmaceuticals, Inc. is 683 410 000 $ Current cash Dicerna Pharmaceuticals, Inc. - the sum of all of the cash a company has on the date of report. Current cash Dicerna Pharmaceuticals, Inc. is 159 111 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
47 603 000 $
-13 067 000 $
-5 939 000 $
-12 928 000 $
-22 051 000 $
-17 150 000 $
-18 496 000 $
-12 243 000 $
-10 150 000 $
-8 794 000 $
-
-
-
-
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
54 023 000 $
54 814 000 $
53 376 000 $
30 086 000 $
22 832 000 $
21 603 000 $
13 784 000 $
11 695 000 $
10 339 000 $
-
-
-
-
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
47 603 000 $
40 956 000 $
48 875 000 $
40 448 000 $
8 035 000 $
5 682 000 $
3 107 000 $
1 541 000 $
1 545 000 $
1 545 000 $
1 545 000 $
1 418 000 $
474 000 $
252 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
8 035 000 $
5 682 000 $
3 107 000 $
1 541 000 $
1 545 000 $
1 545 000 $
1 545 000 $
1 418 000 $
474 000 $
252 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-29 107 000 $
-31 649 000 $
-22 900 000 $
-33 493 000 $
-32 670 000 $
-25 981 000 $
-28 172 000 $
-19 479 000 $
-15 504 000 $
-13 554 000 $
-15 867 000 $
-15 768 000 $
-15 212 000 $
-15 368 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-29 965 000 $
-36 586 000 $
-21 849 000 $
-31 820 000 $
-30 790 000 $
-23 845 000 $
-26 154 000 $
-18 611 000 $
-19 020 000 $
-35 644 000 $
-15 579 000 $
-15 589 000 $
-15 033 000 $
-15 225 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
56 038 000 $
56 038 000 $
56 038 000 $
56 038 000 $
30 086 000 $
30 086 000 $
21 603 000 $
21 603 000 $
21 603 000 $
21 603 000 $
9 893 000 $
9 786 000 $
9 001 000 $
9 320 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
76 710 000 $
72 605 000 $
71 775 000 $
73 941 000 $
40 705 000 $
31 663 000 $
31 279 000 $
21 020 000 $
17 049 000 $
15 099 000 $
17 412 000 $
17 186 000 $
15 686 000 $
15 620 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
594 500 000 $
618 703 000 $
627 651 000 $
681 762 000 $
320 398 000 $
350 248 000 $
373 364 000 $
405 514 000 $
183 486 000 $
87 612 000 $
101 810 000 $
118 558 000 $
79 834 000 $
91 696 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
683 410 000 $
707 846 000 $
681 738 000 $
732 410 000 $
336 250 000 $
361 396 000 $
383 989 000 $
409 041 000 $
185 508 000 $
89 715 000 $
104 074 000 $
120 884 000 $
82 726 000 $
94 723 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
159 111 000 $
126 023 000 $
204 281 000 $
197 801 000 $
47 226 000 $
100 321 000 $
160 141 000 $
54 239 000 $
46 399 000 $
42 426 000 $
43 790 000 $
68 789 000 $
30 960 000 $
38 777 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
119 361 000 $
95 872 000 $
74 688 000 $
94 055 000 $
29 128 000 $
16 236 000 $
-
-
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
97 816 000 $
113 678 000 $
75 919 000 $
88 730 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
201 883 000 $
201 231 000 $
204 361 000 $
208 348 000 $
29 128 000 $
25 140 000 $
-
-
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
60.04 %
55.68 %
53.22 %
50.94 %
15.70 %
28.02 %
-
-
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
126 404 000 $
137 754 000 $
153 700 000 $
162 168 000 $
134 367 000 $
160 165 000 $
179 628 000 $
200 693 000 $
156 380 000 $
64 575 000 $
87 886 000 $
101 238 000 $
-3 779 000 $
13 268 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-32 000 000 $
-26 055 000 $
72 287 000 $
61 640 000 $
-11 069 000 $
-15 822 000 $
-16 451 000 $
-5 954 000 $
-12 475 000 $
-13 889 000 $
Last revenue report of Dicerna Pharmaceuticals, Inc. was 31/03/2021. According to last financial report total revenue in Dicerna Pharmaceuticals, Inc. was 47 603 000 US dollar and changed by +1 432.120% since last year. Net income in Dicerna Pharmaceuticals, Inc. was -29 965 000 $ in last quartal, net income changes to 0%.
Dicerna Pharmaceuticals, Inc. stocks data
DRNA stock price
Dicerna Pharmaceuticals, Inc. stock price today, DRNA stock quote.
